Stock

Monte Rosa Therapeutics, Inc. GLUE

Market data for GLUE is refreshing — check back shortly.

All stocks Create account to unlock

Overview

GLUE market data

Price History

No market bars yet for GLUE. This page will populate once the next provider sweep lands.

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for GLUE. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

4 captured

Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight · Jul 23, 2026, 5:15 PM

Guggenheim Maintains Buy on Monte Rosa Therapeutics, Raises Price Target to $35 · Jun 30, 2026, 2:00 PM

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences · May 20, 2026, 11:15 AM

8-K filing — Monte Rosa Therapeutics, Inc. (GLUE) · May 7, 2026, 11:05 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock